AGILYSYS INC (AGYS)
US00847J1051 - Common Stock
Overall AGYS gets a fundamental rating of 6 out of 10. We evaluated AGYS against 276 industry peers in the Software industry. AGYS has an excellent financial health rating, but there are some minor concerns on its profitability. AGYS is valued quite expensive, but it does show an excellent growth. This makes AGYS very considerable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year AGYS was profitable.
AGYS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: AGYS reported negative net income in multiple years.
Each year in the past 5 years AGYS had a positive operating cash flow.
1.2 Ratios
The Return On Assets of AGYS (24.71%) is better than 98.18% of its industry peers.
The Return On Equity of AGYS (37.20%) is better than 96.35% of its industry peers.
The Return On Invested Capital of AGYS (4.99%) is better than 79.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 24.71% | ||
| ROE | 37.2% | ||
| ROIC | 4.99% |
ROA(3y)-1.68%
ROA(5y)-7.04%
ROE(3y)-2.74%
ROE(5y)-13.77%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 37.54%, AGYS belongs to the top of the industry, outperforming 97.08% of the companies in the same industry.
AGYS has a Operating Margin of 7.07%. This is in the better half of the industry: AGYS outperforms 78.47% of its industry peers.
With a Gross Margin value of 60.58%, AGYS perfoms like the industry average, outperforming 41.97% of the companies in the same industry.
In the last couple of years the Gross Margin of AGYS has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.07% | ||
| PM (TTM) | 37.54% | ||
| GM | 60.58% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.58%
GM growth 5Y3.82%
2. Health
2.1 Basic Checks
AGYS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
AGYS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for AGYS has been increased compared to 5 years ago.
There is no outstanding debt for AGYS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 13.45 indicates that AGYS is not in any danger for bankruptcy at the moment.
AGYS's Altman-Z score of 13.45 is amongst the best of the industry. AGYS outperforms 94.16% of its industry peers.
AGYS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 13.45 |
ROIC/WACC0.5
WACC10.01%
2.3 Liquidity
AGYS has a Current Ratio of 2.01. This indicates that AGYS is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 2.01, AGYS perfoms like the industry average, outperforming 59.85% of the companies in the same industry.
A Quick Ratio of 1.94 indicates that AGYS should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.94, AGYS perfoms like the industry average, outperforming 58.03% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.01 | ||
| Quick Ratio | 1.94 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 9.47% over the past year.
The Earnings Per Share has been growing by 63.98% on average over the past years. This is a very strong growth
AGYS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.02%.
The Revenue has been growing by 9.23% on average over the past years. This is quite good.
EPS 1Y (TTM)9.47%
EPS 3Y63.98%
EPS 5YN/A
EPS growth Q2Q34.62%
Revenue 1Y (TTM)19.02%
Revenue growth 3Y7.2%
Revenue growth 5Y9.23%
Revenue growth Q2Q21.37%
3.2 Future
AGYS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.49% yearly.
The Revenue is expected to grow by 20.30% on average over the next years. This is a very strong growth
EPS Next Y13.01%
EPS Next 2Y15.49%
EPS Next 3Y20.49%
EPS Next 5YN/A
Revenue Next Year20.3%
Revenue Next 2Y18.43%
Revenue Next 3Y20.3%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
AGYS is valuated quite expensively with a Price/Earnings ratio of 80.24.
AGYS's Price/Earnings ratio is in line with the industry average.
AGYS's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.20.
AGYS is valuated quite expensively with a Price/Forward Earnings ratio of 64.50.
AGYS's Price/Forward Earnings ratio is in line with the industry average.
AGYS is valuated expensively when we compare the Price/Forward Earnings ratio to 21.63, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 80.24 | ||
| Fwd PE | 64.5 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AGYS indicates a somewhat cheap valuation: AGYS is cheaper than 63.87% of the companies listed in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as AGYS.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 95.45 | ||
| EV/EBITDA | 102.75 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of AGYS may justify a higher PE ratio.
A more expensive valuation may be justified as AGYS's earnings are expected to grow with 20.49% in the coming years.
PEG (NY)6.17
PEG (5Y)N/A
EPS Next 2Y15.49%
EPS Next 3Y20.49%
5. Dividend
5.1 Amount
AGYS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AGILYSYS INC
NASDAQ:AGYS (4/25/2024, 7:00:00 PM)
After market: 83.45 0 (0%)83.45
-0.41 (-0.49%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.28B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 80.24 | ||
| Fwd PE | 64.5 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)6.17
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 24.71% | ||
| ROE | 37.2% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 7.07% | ||
| PM (TTM) | 37.54% | ||
| GM | 60.58% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.66
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.01 | ||
| Quick Ratio | 1.94 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)9.47%
EPS 3Y63.98%
EPS 5Y
EPS growth Q2Q
EPS Next Y13.01%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)19.02%
Revenue growth 3Y7.2%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y